NCT04066972

Brief Summary

People with multiple sclerosis (MS) are often offered walking aids and compensatory strategies rather than restorative rehabilitation. We have developed a cool room treadmill training method that uses body-weight support that people with MS fatigue and heat sensitivity can tolerate. Our previous research shows that people with advanced MS use three times more energy for essential tasks such as walking. This project will test whether 10 weeks of body-weight supported treadmill training in a room cooled to 16°C improves walking, fitness and fatigue in people with advanced MS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 9, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 20, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 26, 2019

Completed
Last Updated

August 28, 2019

Status Verified

August 1, 2019

Enrollment Period

12 months

First QC Date

August 20, 2019

Last Update Submit

August 23, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Feasibility of conducting vigorous cool room treadmill training

    Recruitment and retention rates

    10 weeks

  • Feasibility of conducting vigorous cool room treadmill training

    Incidence of adverse events

    10 weeks

  • Feasibility of conducting vigorous cool room treadmill training

    Degree of body-weight support provided by the harness (%)

    10 weeks

  • Feasibility of conducting vigorous cool room treadmill training

    Rest required (minutes)

    10 weeks

Secondary Outcomes (14)

  • Timed 25 foot walk test

    Following completion of the 10-week exercise intervention and 3-months post-exercise intervention

  • Spatiotemporal parameters of gait measured while walking at fast and self-selected pace

    Following completion of the 10-week exercise intervention and 3-months post-exercise intervention

  • Fatigue severity scale

    Following completion of the 10-week exercise intervention and 3-months post-exercise intervention

  • Modified fatigue impact scale

    Following completion of the 10-week exercise intervention and 3-months post-exercise intervention

  • Maximal oxygen consumption during graded exercise test

    Following completion of the 10-week exercise intervention and 3-months post-exercise intervention

  • +9 more secondary outcomes

Study Arms (1)

Single arm

EXPERIMENTAL
Other: Body-weight supported treadmill training in a room cooled to 16°C

Interventions

A total of 30 training sessions will be conducted in 10 weeks for 30 minutes per session and 3 times per week in a cool room (16⁰ C) on a treadmill that is equipped with safety straps to prevent falls. A pneumatic harness system will be used to provide 10% body-weight support during training sessions. The participants will start exercising on the treadmill at 80% of their self-selected walking speed with 1% incline and will increase as per their tolerance (will progress weekly based on 40-65% heart rate reserve). Heart rate, perceived fatigue and rating of perceived exertion will be monitored continuously during exercise sessions. Initial training will commence with intermittent rest periods \[1 to 5 minutes\] as requested by the participants and will be progressed to a maximum of 30-minute continuous treadmill walking.

Also known as: Vigorous cool room treadmill training
Single arm

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinically definite MS
  • relapse-free in the previous 3 months
  • requiring ambulatory assistive devices (EDSS 6.0-7.0)
  • negative PAR-Q screen for risk factors
  • greater than 6-weeks post Botulinum Toxin injection (if received) in the lower extremity

You may not qualify if:

  • pregnancy or intention of becoming pregnant
  • finished a drug/device study in the last 30 days
  • over 75 years of age
  • unable to control bowel and bladder on physical exertion
  • currently attending physical rehabilitation
  • having no difficulty walking in the community (self-selected walking speed \>120 cm/s)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial University of Newfoundland

St. John's, Newfoundland and Labrador, A1A 1E5, Canada

Location

Related Publications (2)

  • Chaves AR, Devasahayam AJ, Kelly LP, Pretty RW, Ploughman M. Exercise-Induced Brain Excitability Changes in Progressive Multiple Sclerosis: A Pilot Study. J Neurol Phys Ther. 2020 Apr;44(2):132-144. doi: 10.1097/NPT.0000000000000308.

  • Devasahayam AJ, Chaves AR, Lasisi WO, Curtis ME, Wadden KP, Kelly LP, Pretty R, Chen A, Wallack EM, Newell CJ, Williams JB, Kenny H, Downer MB, McCarthy J, Moore CS, Ploughman M. Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study. BMC Neurol. 2020 Jan 22;20(1):33. doi: 10.1186/s12883-020-1611-0.

MeSH Terms

Conditions

Multiple SclerosisGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This is a 'proof-of-principle/feasibility' within group repeated measures study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine

Study Record Dates

First Submitted

August 20, 2019

First Posted

August 26, 2019

Study Start

July 10, 2018

Primary Completion

July 9, 2019

Study Completion

July 9, 2019

Last Updated

August 28, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

The data supporting this study are available at request from the corresponding author at the Memorial University of Newfoundland, Canada.

Locations